Zhi Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zhi Wang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Hui Dong
Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3 shared publications - Hao Su
Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, China
2 shared publications Minmin Gong
Department of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
2 shared publications- Yueheng Tang
Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China; Department of Rehabilitation Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430030, China
2 shared publications - Dongmei Huang
Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China
1 shared publication - Fuer Lu
Department of Integrated Traditional Chinese and Western Medicine, Tongji Medical College, Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China
1 shared publication
Latest Publications
- 19 November 2024
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (2) , 102459
Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?
- 19 November 2024
- Published by Elsevier in Journal of Clinical and Experimental Hepatology
- Vol. 15 (2) , 102459
Sex Hormone: A Potential Target at Treating Female Metabolic Dysfunction-Associated Steatotic Liver Disease?
- Open Access
- 15 June 2021
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 21 (1) , 1-8
The role of FDX1 in granulosa cell of Polycystic ovary syndrome (PCOS)
Background: To explore the development mechanism of PCOS and Transcriptomics was applied to seek the key gene. Methods: Transcriptomics marked by UID (unique identifier) technique of granulosa cell in PCOS and control women was carried out and key gene was picked up. Then the key gene in granulosa cell was measured by RT-PCR. Two PCOS models modeling with Letrozole and Testosterone Propionate were implemented and the key gene in granulosa cell of ovary was measured by immunohistochemistry to verify the relation with PCOS. Results: GO-enrich of transcriptomics concentrated in domain steroid metabolism and domain mitochondria. Different genes were sought from coexisting in both domain steroid metabolism and domain mitochondria. Finally, five different genes including CYP11A1、CYB5R1、STAR、FDX1 and AMACR were obtained. RT-PCR was implemented to furtherly verify the downregulating mRNA of FDX1 in PCOS, which showed the consistent outcome with the transcriptomics. Level of FDX1 protein in granulosa cell of antral follicle in two PCOS models was measured and decreased. Conclusions: FDX1 was related with steroid metabolism and mitochondrial and may participate in the development of PCOS.
- 15 June 2021
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 21 (1) , 1-8
Open AccessThe role of FDX1 in granulosa cell of Polycystic ovary syndrome (PCOS)
Background: To explore the development mechanism of PCOS and Transcriptomics was applied to seek the key gene. Methods: Transcriptomics marked by UID (unique identifier) technique of granulosa cell in PCOS and control women was carried out and key gene was picked up. Then the key gene in granulosa cell was measured by RT-PCR. Two PCOS models modeling with Letrozole and Testosterone Propionate were implemented and the key gene in granulosa cell of ovary was measured by immunohistochemistry to verify the relation with PCOS. Results: GO-enrich of transcriptomics concentrated in domain steroid metabolism and domain mitochondria. Different genes were sought from coexisting in both domain steroid metabolism and domain mitochondria. Finally, five different genes including CYP11A1、CYB5R1、STAR、FDX1 and AMACR were obtained. RT-PCR was implemented to furtherly verify the downregulating mRNA of FDX1 in PCOS, which showed the consistent outcome with the transcriptomics. Level of FDX1 protein in granulosa cell of antral follicle in two PCOS models was measured and decreased. Conclusions: FDX1 was related with steroid metabolism and mitochondrial and may participate in the development of PCOS.
- 1 June 2021
- Published by Elsevier in Journal of Affective Disorders
- Vol. 288, 1-9
The Therapeutic Effect of Aromatherapy on Insomnia: a Meta-Analysis
- 1 June 2021
- Published by Elsevier in Journal of Affective Disorders
- Vol. 288, 1-9
The Therapeutic Effect of Aromatherapy on Insomnia: a Meta-Analysis
- Open Access
- 4 May 2021
- Published by Springer Nature in Research Square
Potential Molecular Mechanisms of JTW in the Treatment of Diabetes Mellitus and Depression Based on Network Pharmacology
Background: The incidence of diabetes mellitus (DM) and depression is increasing year by year around the world, bringing a serious burden to patients and their families. As a well-known traditional Chinese medicine (TCM), Jiao-tai-wan (JTW) has obvious hypoglycemic and antidepressant effects, but its specific targets and mechanisms are still unclear.Methods: The active compounds and corresponding targets of JTW were screened by the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and the Bioinformatics Analysis Tool for Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM). The GeneCards, the Online Mendelian Inheritance in Man (OMIM), the DrugBank and the Therapeutic Target Database (TTD) were used to collect targets of DM and depression. After sorting out the intersection targets of drugs and diseases, the Cytoscape software was used to perform a "Drug-Compounds-Targets-Disease (D-C-T-D)" network to analyze the active compounds of JTW, and the protein-protein interaction (PPI) network was constructed by the STRING database to screen and analyze the key target proteins. Finally, the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses of the intersection targets were carried out by the database for annotation, visualization and integrated discovery (DAVID). Results: 28 active compounds and 484 corresponding targets of JTW, 1407 DM targets and 1842 depression targets were collected by screening the above databases, and a total of 117 targets were obtained after taking the intersection. JTW plays a role in reducing blood glucose level and antidepressant mainly through active compounds such as quercetin, styrene, cinnamic acid, ethyl cinnamate, (R)-Canadine, palmatine and berberine, etc., the key targets of its therapeutic effect include insulin (INS), protein kinase B1 (AKT1), interleukin-6 (IL-6), vascular endothelial growth factor A (VEGF-A), tumor necrosis factor (TNF) and so on, mainly involved in HIF-1 signal pathway, pathways in cancer, Hepatitis B, TNF signal pathway, PI3K-Akt signal pathway and MAPK signaling pathway, etc.Conclusion: In this paper, the possible mechanism of JTW on DM and depression was explored by network pharmacology, reflecting the characteristics of multi-component, multi-target and multi-pathway, which provides a theoretical basis for the experimental research and clinical application of JTW in the future.
- 4 May 2021
- Published by Springer Nature in Research Square
Open AccessPotential Molecular Mechanisms of JTW in the Treatment of Diabetes Mellitus and Depression Based on Network Pharmacology
Background: The incidence of diabetes mellitus (DM) and depression is increasing year by year around the world, bringing a serious burden to patients and their families. As a well-known traditional Chinese medicine (TCM), Jiao-tai-wan (JTW) has obvious hypoglycemic and antidepressant effects, but its specific targets and mechanisms are still unclear.Methods: The active compounds and corresponding targets of JTW were screened by the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) and the Bioinformatics Analysis Tool for Molecular Mechanism of Traditional Chinese Medicine (BATMAN-TCM). The GeneCards, the Online Mendelian Inheritance in Man (OMIM), the DrugBank and the Therapeutic Target Database (TTD) were used to collect targets of DM and depression. After sorting out the intersection targets of drugs and diseases, the Cytoscape software was used to perform a "Drug-Compounds-Targets-Disease (D-C-T-D)" network to analyze the active compounds of JTW, and the protein-protein interaction (PPI) network was constructed by the STRING database to screen and analyze the key target proteins. Finally, the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses of the intersection targets were carried out by the database for annotation, visualization and integrated discovery (DAVID). Results: 28 active compounds and 484 corresponding targets of JTW, 1407 DM targets and 1842 depression targets were collected by screening the above databases, and a total of 117 targets were obtained after taking the intersection. JTW plays a role in reducing blood glucose level and antidepressant mainly through active compounds such as quercetin, styrene, cinnamic acid, ethyl cinnamate, (R)-Canadine, palmatine and berberine, etc., the key targets of its therapeutic effect include insulin (INS), protein kinase B1 (AKT1), interleukin-6 (IL-6), vascular endothelial growth factor A (VEGF-A), tumor necrosis factor (TNF) and so on, mainly involved in HIF-1 signal pathway, pathways in cancer, Hepatitis B, TNF signal pathway, PI3K-Akt signal pathway and MAPK signaling pathway, etc.Conclusion: In this paper, the possible mechanism of JTW on DM and depression was explored by network pharmacology, reflecting the characteristics of multi-component, multi-target and multi-pathway, which provides a theoretical basis for the experimental research and clinical application of JTW in the future.